Inflazyme Pharmaceuticals Limited

Therapeutics to treat serious inflammatory diseases.

Contact Details: 425-5600 Parkwood Way Richmond British Columbia V6V 2M2 Canada Tel: 604 733 5181 Fax: 604 733 5281 Email: WWW: www.inflazyme.com/

Loading...

Recent Publications by Inflazyme Pharmaceuticals Limited:
IPL576,092, a novel anti-inflammatory compound, inhibits leukocyte infiltration and changes in lung function in response to allergen challenge. IPL576,092, a lead compound from a novel class of polyhydroxylated...	9th March, 2005	Inflazyme Pharmaceuticals Ltd, 425-5600 Parkwood Way, Richmond, BC, Canada	Pulm Pharmacol Ther. 2004;17(5):309-18. DOI Direct Link
Efficient synthesis of IPL576,092: a novel anti-asthma agent. An enantioseletive synthesis of the novel anti-asthma agent IRL576,092 (2)...	26th November, 2002	Inflazyme Pharmaceuticals Ltd., Suite 425, 5600 Parkwood Way, Richmond,	J Org Chem. 2002 May 31;67(11):3908-10.

BioNews Results for Inflazyme Pharmaceuticals Limited:
Poniard Pharmaceuticals to Host Conference Call and Webcast at 8:00 a.m. Eastern Time Tomorrow to Discuss Results of Pivotal Phase 3 SPEAR Trial in Small Cell Lung Cancer	FinanzNachrichten.de:  Nov 16 2009 12:34AM Matching: pharmaceuticals
Poniard Pharmaceuticals to Host Conference Call and Webcast at 8:00 a.m. Eastern Time Tomorrow to Discuss Resu	Washington Business Journal:  Nov 16 2009 1:25AM Matching: pharmaceuticals
Poniard Pharmaceuticals to Host Conference Call and Webcast at 8:00 a.m. Eastern Time Tomorrow to Discuss Resu	St Louis Business Journal:  Nov 16 2009 12:45AM Matching: pharmaceuticals
Poniard Pharmaceuticals to Host Conference Call and Webcast at 8:00 a.m. Eastern Time Tomorrow to Discuss Resu	San Jose Business Journal:  Nov 16 2009 12:35AM Matching: pharmaceuticals
Poniard Pharmaceuticals to Host Conference Call and Webcast at 8:00 a.m. Eastern Time Tomorrow to Discuss Resu	Reuters:  Nov 16 2009 12:43AM Matching: pharmaceuticals
Promote your company here: BioNewsCast - Press Release Distribution	→View more Inflazyme Pharmaceuticals Limited news.

Inflazyme Pharmaceuticals Limited Clinical Trials:
Control of Asthma Patients Symptomatic on Inhaled Corticosteroids

Inflazyme Pharmaceuticals Limited Patents:
US Patent No.	Title
7112580	3-nitrogen-6, 7-dioxygen steroids and uses related thereto
6046185	6,7-oxygenated steroids and uses related thereto
6458829	Substituted .gamma.-phenyl-.DELTA.-lactones and analogs thereof and uses related thereto
6555572	Benzylated PDE4 inhibitors
6635629	3-nitrogen-6,7-dioxygen steroids and uses related thereto
→View more Inflazyme Pharmaceuticals Limited patents.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 290 times since April 2007, the link to the organisation's website has been followed 68 times

Search for more companies in Richmond

Search for more companies in British Columbia

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Inflazyme Pharmaceuticals Limited